Timothy Yap MD Anderson Cancer Center

5 (451) ·

$ 7.00 ·

In stock

Description

Updates on Advanced Breast Cancer: Local Management and Other New

Shubham Pant MD Anderson Cancer Center

Trial results suggest new approaches for difficult-to-treat adult

Combination of camonsertib plus PARPi shows clinical activity in

VT3989YAP, a YAP/TEAD inhibitor, in mesothelioma and NF2

Timothy A. Yap, MBBS, PhD, FRCP, on COVID-19 Vaccination for

ASCO: Targeted metabolic inhibitor stabilizes solid tumors in 60

Stat4Onc Annual Symposium

Novel Biomarkers “Absolutely Critical” to Ending “One-Size-Fits

Trial results suggest new approaches to treat rare cancers - AACR

Timothy Yap, BSc (Hons), MBBS, MRCP

Combining radiotherapy with immunotherapy - ecancer

The phase 1 trial setup toolbox - Endpoints Webinars